Lurasidone is a medication that works in the brain to treat schizophrenia. It is also known as a second generation antipsychotic (SGA) or atypical antipsychotic. Lurasidone rebalances dopamine and serotonin to improve thinking, mood, and behavior.
Can lurasidone cause NMS?
Neuroleptic Malignant Syndrome (NMS) Rarely, lurasidone can cause deadly symptoms. NMS can affect your heart, muscles, and kidneys. See your doctor right away if you get: A high fever.
What neurotransmitters does lurasidone affect?
Lurasidone acts mainly by blocking the receptors for the neurotransmitters dopamine, 5- hydroxytryptamine (also called serotonin) and noradrenaline.
What type of drug is lurasidone?
Lurasidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Is Latuda bad for kidneys?
Seniors: Seniors with dementia who take lurasidone or other similar medications are at an increased risk of dying. There may be a higher risk of liver, kidney, and heart problems, and a higher risk of drug interactions for seniors. Talk to your doctor about the risks and benefits of using this medication.
Does Latuda affect kidneys?
Does Latuda cause memory loss?
No, Latuda isn’t known to cause memory loss. This side effect wasn’t reported in studies of the drug. But memory loss is a symptom of bipolar disorder and schizophrenia (conditions Latuda is used to treat). So it’s possible you may experience memory loss while using Latuda to treat these conditions.
What is the solubility of lurasidone hydrochloride?
Lurasidone HCl has an aqueous solubility of 0.224 mg/mL in water with maximum solubility of 0.349 mg/mL in pH 3.5 buffer. Lurasidone Hydrochloride, is manufactured by Dainippon Sumitomo Pharma at their Oita plant in Japan and the sponsor referred to DMF #16059 through a letter of authorization from the DMF holder.
What is the drug lurasidone used to treat?
Lurasidone is used (generally as the hydrochloride salt) as an atypical antipsychotic for the treatment of schizophrenia. It has a role as an adrenergic antagonist, a dopaminergic antagonist, a serotonergic antagonist and a second generation antipsychotic. It is a 1,2-benzisothiazole, a N-arylpiperazine, a bridged compound and a dicarboximide.
What is the conjugate base of a lurasidone (1+)?
It is a conjugate base of a lurasidone (1+). Lurasidone is an atypical antipsychotic developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States.
What are the contraindications for lurasidone?
As with other antipsychotic agents, lurasidone should be used with caution in patients with a history of seizures or with conditions that may lower the seizure threshold (e.g., dementia of the Alzheimer’s type); conditions that lower the seizure threshold may be more prevalent in patients 65 years of age or older.
